Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Flunisolide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 7/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.61 |
| ▸ | LMNA | P02545 | 7/20 | 0.61 |
| ▸ | PGR | P06401 | 7/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.61 |
| ▸ | AR | P10275 | 4/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flunisolide SCHEMBL20915050 | 0.95 | CYP3A4 (0.69) | CYP3A4LMNANR3C1PGRHIF1A | |
| Triamcinolone Acetonide SCHEMBL20915153 | 0.90 | HIF1A (0.77) | CYP3A4LMNANR3C1PGRHIF1A | |
| Flunisolide SCHEMBL221433 | 0.87 | PGR (0.73) | CYP3A4LMNANR3C1PGRHIF1A | |
| Desonide SCHEMBL11778722 | 0.87 | CYP3A4 (0.73) | CYP3A4LMNANR3C1PGRHIF1A | |
| Desonide SCHEMBL2115498 | 0.86 | CYP3A4 (0.75) | CYP3A4LMNANR3C1PGRHIF1A | |
| Fluocinolone Acetonide SCHEMBL5501859 | 0.85 | HIF1A (0.77) | CYP3A4LMNANR3C1PGRHIF1A | |
| Triamcinolone Acetonide SCHEMBL28103100 | 0.84 | CYP3A4 (0.87) | CYP3A4LMNANR3C1PGRHIF1A | |
| Triamcinolone Acetonide SCHEMBL1561091 | 0.83 | HIF1A (0.89) | CYP3A4LMNANR3C1PGRHIF1A | |
| Triamcinolone Acetonide SCHEMBL1446089 | 0.83 | HIF1A (0.89) | CYP3A4LMNANR3C1PGRHIF1A | |
| Fluocinolone Acetonide SCHEMBL2251974 | 0.82 | NR3C1 (0.82) | CYP3A4LMNANR3C1PGRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10117974-B2 | Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions | ARROW INTERNATIONAL, INC. (US) | 2018-11-06 | — | — | US | disclosed |
| US-10016532-B2 | Non-fouling, anti-microbial, anti-thrombogenic graft compositions | ARROW INTERNATIONAL, INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-9096703-B2 | Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions | SEMPRUS BIOSCIENCES CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| US-20150056411-A1 | NON-FOULING, ANTI-MICROBIAL, ANTI-THROMBOGENIC GRAFT COMPOSITIONS | TELEFLEX LIFE SCIENCES LIMITED (MT) | 2015-02-26 | — | — | US | disclosed |
| US-20150045515-A1 | NON-FOULING, ANTI-MICROBIAL, ANTI-THROMBOGENIC GRAFT-FROM COMPOSITIONS | TELEFLEX LIFE SCIENCES LIMITED (MT) | 2015-02-12 | — | — | US | disclosed |
| US-20110305898-A1 | NON-FOULING, ANTI-MICROBIAL, ANTI-THROMBOGENIC GRAFT COMPOSITIONS | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2011-12-15 | — | — | US | disclosed |